PRESS RELEASE published on 05/07/2025 at 14:36, 8 months 28 days ago EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG Carl Zeiss Meditec AG announces change of President and CEO, Dr. Markus Weber, to be succeeded by Maximilian Foerst. Handover on May 31, 2025. Foerst appointed as new Executive Board member of Carl Zeiss AG Carl Zeiss Meditec AG President CEO Change Maximilian Foerst
BRIEF published on 04/15/2025 at 09:02, 9 months 20 days ago Carl Zeiss Meditec Reports Strong Q2 Earnings for 2024/25 Revenue Growth Refractive Surgery China Market Q2 2024/25 Earnings EBITA Increase
BRIEF published on 04/15/2025 at 09:02, 9 months 20 days ago Carl Zeiss Meditec annonce de solides résultats au deuxième trimestre 2024/25 Croissance Des Revenus Marché Chinois Chirurgie Réfractive Résultats Du Deuxième Trimestre 2024/25 Augmentation De L'EBITA
PRESS RELEASE published on 04/15/2025 at 08:57, 9 months 20 days ago EQS-Adhoc: Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25 Carl Zeiss Meditec AG achieves significant earnings increase in Q2 2024/25, with revenue of EUR 560 million and EBITA of EUR 78 million Revenue Growth Carl Zeiss Meditec AG Earnings Increase EBITA Q2 2024/25
BRIEF published on 02/27/2025 at 10:43, 11 months 6 days ago Le ZEISS VISUMAX 800 obtient l'approbation de la Chine Marché Chinois Approbation Réglementaire ZEISS VISUMAX 800 Laser Femtoseconde Amélioration Chirurgicale
BRIEF published on 02/27/2025 at 10:43, 11 months 6 days ago ZEISS VISUMAX 800 Gains China Approval Regulatory Approval China Market ZEISS VISUMAX 800 Femtosecond Laser Surgical Enhancement
PRESS RELEASE published on 02/27/2025 at 10:38, 11 months 6 days ago ZEISS VISUMAX 800 with SMILE pro software receives approval in China ZEISS VISUMAX 800 with SMILE pro software receives approval in China, providing faster treatment, flexibility, and workflow enhancements for refractive surgeons ZEISS VISUMAX 800 Femtosecond Laser SMILE Pro Software China Approval Refractive Surgeons
BRIEF published on 02/12/2025 at 07:03, 11 months 21 days ago Carl Zeiss Meditec annonce une croissance modeste de son chiffre d'affaires pour le premier trimestre 2024/25 Carl Zeiss Meditec Croissance Des Revenus Ophtalmologie Premier Trimestre 2024/25 Performances Mondiales
BRIEF published on 02/12/2025 at 07:03, 11 months 21 days ago Carl Zeiss Meditec Reports Modest Revenue Growth for Q1 2024/25 Revenue Growth Carl Zeiss Meditec Ophthalmology Q1 2024/25 Global Performance
PRESS RELEASE published on 02/12/2025 at 06:58, 11 months 21 days ago Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25 Carl Zeiss Meditec reports slight revenue growth of +3.2% in the first three months of fiscal year 2024/25, driven by order entry and order backlog recovery Revenue Growth Carl Zeiss Meditec Q1 Results 2024/25 Fiscal Year DORC Acquisition
Published on 02/05/2026 at 09:05, 1 hour 44 minutes ago BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 9 hours 14 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 10 hours 49 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 12 hours 24 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/05/2026 at 10:05, 44 minutes ago VT Markets Powers Reliable Gold Trading Amid Extreme Market Volatility
Published on 02/05/2026 at 10:05, 44 minutes ago Signing of strategic technology supply and offtake agreement with Carester, US$20 million equity investment from the Industrial Development Corporation, and commencement of DFS for the Zandkopsdrift magnet rare earths and battery grade manganese
Published on 02/05/2026 at 09:00, 1 hour 49 minutes ago Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY
Published on 02/05/2026 at 09:00, 1 hour 49 minutes ago Original-Research: Limes Schlosskliniken AG (von NuWays AG): BUY
Published on 02/05/2026 at 09:00, 1 hour 49 minutes ago Original-Research: Semperit AG Holding (von NuWays AG): BUY
Published on 02/04/2026 at 18:04, 16 hours 45 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 16 hours 45 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 17 hours 4 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 17 hours 4 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
